圣达生物大跌5.14% 维生素类产品毛利总额减少

智选洞察05-08

05月08日，圣达生物（603079）股价大幅下跌，截至09点30分，圣达生物下跌5.14%，报13.30元/股，成交2133万元，换手率0.94%。消息解读2023年，主营维生素类产品由于下游需求持续减弱，终端用户采购意愿依旧低迷，加之维生素产能惯性释放，市场供需失衡使得公司维生素类产品市场价格大幅下降，压缩了维生素的利润空间，导致主营维生素类产品毛利总额减少。公司拟对存在减值迹象的资产计提减值...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2433668277?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-05-08 09:30","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2433668277","market":"sh","top_or_hot":-1,"title":"圣达生物大跌5.14% 维生素类产品毛利总额减少","media":"智选洞察","content":"<div>\n<p>05月08日，圣达生物（603079）股价大幅下跌，截至09点30分，圣达生物下跌5.14%，报13.30元/股，成交2133万元，换手率0.94%。消息解读2023年，主营维生素类产品由于下游需求持续减弱，终端用户采购意愿依旧低迷，加之维生素产能惯性释放，市场供需失衡使得公司维生素类产品市场价格大幅下降，压缩了维生素的利润空间，导致主营维生素类产品毛利总额减少。公司拟对存在减值迹象的资产计提减值...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405080936227926669a&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>圣达生物大跌5.14% 维生素类产品毛利总额减少</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n圣达生物大跌5.14% 维生素类产品毛利总额减少\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-05-08 09:30 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405080936227926669a&s=b><strong>智选洞察</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>05月08日，圣达生物（603079）股价大幅下跌，截至09点30分，圣达生物下跌5.14%，报13.30元/股，成交2133万元，换手率0.94%。消息解读2023年，主营维生素类产品由于下游需求持续减弱，终端用户采购意愿依旧低迷，加之维生素产能惯性释放，市场供需失衡使得公司维生素类产品市场价格大幅下降，压缩了维生素的利润空间，导致主营维生素类产品毛利总额减少。公司拟对存在减值迹象的资产计提减值...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405080936227926669a&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"603079","symbol_name":"圣达生物","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405080936227926669a&s=b","article_id":"2433668277","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405080936227926669a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2433668277","pubTimestamp":1715131846,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"05月08日，圣达生物股价大幅下跌，截至09点30分，圣达生物下跌5.14%，报13.30元/股，成交2133万元，换手率0.94%。在股票连续3个交易日累计涨幅超20%后，圣达生物6日发布异动公告称，公司及实控人不存在其他应披露而未披露的重大信息。最新财报显示，今年一季报，圣达生物实现营业收入1.85亿元，同比增长9.19%，净利润为381.31万元，同比增长9.22%，基本每股收益为0.02元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"603079":"圣达生物"},"translate_title":"Shengda Biotech plummeted 5.14%, and the total gross profit of vitamin products decreased","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"603079":1},"content_text":"05月08日，圣达生物（603079）股价大幅下跌，截至09点30分，圣达生物下跌5.14%，报13.30元/股，成交2133万元，换手率0.94%。消息解读2023年，主营维生素类产品由于下游需求持续减弱，终端用户采购意愿依旧低迷，加之维生素产能惯性释放，市场供需失衡使得公司维生素类产品市场价格大幅下降，压缩了维生素的利润空间，导致主营维生素类产品毛利总额减少。公司拟对存在减值迹象的资产计提减值准备，计提各类资产减值损失合计为5397.03万元，将减少公司2023年度净利润5397.03万元。在股票连续3个交易日累计涨幅超20%后，圣达生物6日发布异动公告称，公司及实控人不存在其他应披露而未披露的重大信息。公司请投资者注意交易风险，理性决策，审慎投资。资金动向截止发稿，圣达生物获得主力净流入19万元，其中超大单流入16万元，大单流入2万元。数据显示，该股今日净流入较近5日净流入均值增加501万元。主营业务及业绩圣达生物公司主营业务为从事生物素和生物保鲜剂研发生产的企业之一，为全球生物素、叶酸主要供应商，长期致力于维生素、生物保鲜剂、食品添加剂和饲料添加剂的研发、生产和销售。最新财报显示，今年一季报，圣达生物实现营业收入1.85亿元，同比增长9.19%，净利润为381.31万元，同比增长9.22%，基本每股收益为0.02元。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2433668277"}